当前位置:首页 >财报库 > 报告详情

直觉外科Intuitive Surgical(ISRG)2025年10-K年度报告「NASDAQ」(英文版)(187页).pdf

上传人: 1****1 编号:1159971 2026-03-18 187页 2.12MB

下载:

1、Table of ContentsUNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549 FORM 10-K(MARK ONE)ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF1934For the fiscal year ended December 31,2025ORTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXC

2、HANGE ACTOF 1934For the transition period from to Commission file number 000-30713Intuitive Surgical,Inc.(Exact name of Registrant as specified in its Charter)Delaware 77-0416458(State or Other Jurisdiction of Incorporation or Organization)(I.R.S.Employer Identification Number)1020 Kifer RoadSunnyva

3、le,California 94086(Address of principal executive offices)(Zip Code)(408)523-2100(Registrants telephone number,including area code)Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading Symbol(s)Name of each exchange on which registeredCommon Stock,par value$0.001 per

4、shareISRGThe Nasdaq Global Select MarketSecurities registered pursuant to Section 12(g)of the Act:NoneIndicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes No Indicate by check mark if the registrant is not required to file reports

5、pursuant to Section 13 or Section 15(d)of the Act.Yes No Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of1934 during the preceding 12 months(or for such shorter period that the registrant was required t

6、o file such reports),and(2)has been subject to such filingrequirements for the past 90 days.Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T(232.405 of this chapter)during the

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1. **公司概况**:Intuitive Surgical(直觉外科)是全球领先的机器人辅助手术技术公司,核心产品为da Vinci手术系统和Ion内窥镜系统,用于微创手术和诊断。 2. **核心数据**:截至2025年12月31日,公司市值约1939亿美元,流通股数3.55亿股(2026年1月28日)。 3. **业务布局**:提供手术系统、器械配件、培训服务及数字化解决方案(如3D建模、My Intuitive应用),覆盖泌尿、妇科、胸外科等70余项临床应用。 4. **风险因素**:面临竞争加剧、监管合规(如FDA审批)、供应链依赖、诉讼风险及宏观经济波动等挑战。 5. **战略目标**:通过“五重目标”(Quintuple Aim)提升患者疗效、体验及医疗效率,同时降低治疗成本。
**公司使命是什么?** **核心产品有哪些?** **面临哪些风险?**
客服
商务合作
小程序
服务号
折叠